Hong, Charles C.
University of Maryland, Baltimore
6 papers on CoChatORCID 0000-0002-0424-8252
Most cited papers
- Verified
Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk
Domanski, M. J., Tian, X., Wu, C. O., Reis, J. P., Dey, A. K., Gu, Y., Zhao, L., Bae, S., Liu, K., Hasan, A. A., et al. (2020) · Journal of the American College of Cardiology
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 411
- Verified
Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats
Theurl, I., Schroll, A., Sonnweber, T., Nairz, M., Theurl, M., Willenbacher, W., Eller, K., Wolf, D., Seifert, M., Sun, C. C., et al. (2011) · Blood
Iron Metabolism and DisordersErythropoietin and Anemia Treatment
Cited by 189
- Verified
Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice
Wang, L., Harrington, L., Trebicka, E., Shi, H. N., Kagan, J. C., Hong, C. C., Lin, H. Y., Babitt, J. L., & Cherayil, B. J. (2009) · Journal of Clinical Investigation
Immune Response and InflammationIron Metabolism and Disorders
Cited by 162
- Verified
Pharmacological Suppression of Hepcidin Increases Macrophage Cholesterol Efflux and Reduces Foam Cell Formation and Atherosclerosis
Saeed, O., Otsuka, F., Polavarapu, R., Karmali, V., Weiss, D., Davis, T., Rostad, B., Pachura, K., Adams, L., Elliott, J., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology
Cholesterol and Lipid MetabolismAtherosclerosis and Cardiovascular Diseases
Cited by 146
- Verified
The E3 ubiquitin ligase component, Cereblon, is an evolutionarily conserved regulator of Wnt signaling
Shen, C., Nayak, A., Neitzel, L. R., Adams, A. A., Silver-Isenstadt, M., Sawyer, L. M., Benchabane, H., Wang, H., Bunnag, N., Li, B., et al. (2021) · Nature Communications
Wnt/β-catenin signaling in development and cancerUbiquitin and proteasome pathways
Cited by 43
- Verified
BMP2 signals loss of epithelial character in epicardial cells but requires the Type III TGFβ receptor to promote invasion
Hill, C. R., Sanchez, N. S., Love, J. D., Arrieta, J. A., Hong, C. C., Brown, C. B., Austin, A. F., & Barnett, J. V. (2012) · Cellular Signalling
TGF-β signaling in diseasesCongenital heart defects research
Cited by 40
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free